Cargando…

Association between noninvasive assessment of liver fibrosis and coronary artery calcification progression in patients with nonalcoholic fatty liver disease

Advanced liver fibrosis and coronary artery calcification (CAC) progression has been reported to correlate with cardiovascular disease. This study investigated the association between noninvasive liver fibrosis score and CAC progression in patients with nonalcoholic fatty liver disease (NAFLD). We i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jiwoo, Kim, Hwi Seung, Cho, Yun Kyung, Kim, Eun Hee, Lee, Min Jung, Bae, In Yong, Jung, Chang Hee, Park, Joong-Yeol, Kim, Hong-Kyu, Lee, Woo Je
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591518/ https://www.ncbi.nlm.nih.gov/pubmed/33110139 http://dx.doi.org/10.1038/s41598-020-75266-4

Ejemplares similares

Association of Myosteatosis with Nonalcoholic Fatty Liver Disease, Severity, and Liver Fibrosis Using Visual Muscular Quality Map in Computed Tomography
por: Kim, Hwi Seung, et al.
Publicado: (2023)

Triglyceride Glucose-Waist Circumference Is Superior to the Homeostasis Model Assessment of Insulin Resistance in Identifying Nonalcoholic Fatty Liver Disease in Healthy Subjects
por: Kim, Hwi Seung, et al.
Publicado: (2021)

Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
por: Yu, Jung Hwan, et al.
Publicado: (2023)

The impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcification
por: Cho, Yun Kyung, et al.
Publicado: (2018)

Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease
por: Kim, Young Seok, et al.
Publicado: (2013)

Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population
por: Kang, Yu Mi, et al.
Publicado: (2017)

Association of Myosteatosis with Nonalcoholic Fatty Liver Disease, Severity, and Liver Fibrosis Using Visual Muscular Quality Map in Computed Tomography (Diabetes Metab J 2023;47:104-17)
por: Kim, Hwi Seung, et al.
Publicado: (2023)

Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease
por: Kim, Min Chul, et al.
Publicado: (2020)

Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
por: Yu, Su Jong, et al.
Publicado: (2015)

Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease
por: Song, Do Seon, et al.
Publicado: (2019)

Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease
por: Lee, Dae Ho
Publicado: (2020)

Noninvasive indices for predicting nonalcoholic fatty liver disease in patients with chronic kidney disease
por: Choe, A Reum, et al.
Publicado: (2020)

Dulaglutide as an Effective Replacement for Prandial Insulin in Kidney Transplant Recipients with Type 2 Diabetes Mellitus: A Retrospective Review
por: Kim, Hwi Seung, et al.
Publicado: (2021)

Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
por: Buzzetti, Elena, et al.
Publicado: (2015)

Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis
por: Jung, Chan-Hee, et al.
Publicado: (2020)

Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity
por: Kim, Hong-Kyu, et al.
Publicado: (2023)

Liver fibrosis is associated with risk for colorectal adenoma in patients with nonalcoholic fatty liver disease
por: Kim, Min Cheol, et al.
Publicado: (2019)

Noninvasive Markers for the Diagnosis of Nonalcoholic Fatty Liver Disease
por: Kim, Sang Yong
Publicado: (2013)

Clinical Efficacy of Quadruple Oral Therapy for Type 2 Diabetes in Real-World Practice: A Retrospective Observational Study
por: Cho, Yun Kyung, et al.
Publicado: (2020)

Dulaglutide as an Add-on to Insulin in Type 2 Diabetes; Clinical Efficacy and Parameters Affecting the Response in Real-World Practice
por: Lee, Jiwoo, et al.
Publicado: (2019)

Prognostic Value of Triglyceride and Glucose Index for Incident Type 2 Diabetes beyond Metabolic Health and Obesity
por: Kim, Hwi Seung, et al.
Publicado: (2021)

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
por: Park, Huiyul, et al.
Publicado: (2023)

Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Baek, Jung-Hwan, et al.
Publicado: (2023)

Accuracy of Noninvasive Scoring Systems in Assessing Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Han, Sangsoo, et al.
Publicado: (2022)

Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study
por: Lee, Min Jung, et al.
Publicado: (2019)

Hepatoprotective Effect of Kombucha Tea in Rodent Model of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Lee, Chanbin, et al.
Publicado: (2019)

Metabolic health is a determining factor for incident colorectal cancer in the obese population: A nationwide population‐based cohort study
por: Cho, Yun Kyung, et al.
Publicado: (2020)

Differential Effect of Metabolic Health and Obesity on Incident Heart Failure: A Nationwide Population-Based Cohort Study
por: Kim, Hwi Seung, et al.
Publicado: (2021)

The risk of Alzheimer’s disease according to dynamic changes in metabolic health and obesity: a nationwide population-based cohort study
por: Cho, Yun Kyung, et al.
Publicado: (2021)

The Impact of NAFLD and Waist Circumference Changes on Diabetes Development in Prediabetes Subjects
por: Lee, Jiwoo, et al.
Publicado: (2019)

Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease
por: Alqahtani, Saleh A., et al.
Publicado: (2021)

Noninvasive assessment of fibrosis among patients with nonalcoholic fatty liver disease [NAFLD]
por: Bernstein, David, et al.
Publicado: (2022)

From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
por: Kang, Seong Hee, et al.
Publicado: (2021)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Association between nonalcoholic fatty liver disease and coronary artery calcification in postmenopausal women
por: Kim, Min Kyung, et al.
Publicado: (2015)

Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
por: Lee, Jae Seung, et al.
Publicado: (2021)

Prospective comparison among transient elastography, supersonic shear imaging, and ARFI imaging for predicting fibrosis in nonalcoholic fatty liver disease
por: Lee, Myoung Seok, et al.
Publicado: (2017)

Clinical Efficacy and Parameters Affecting the Response to Dulaglutide Treatment in Patients with Type 2 Diabetes: A Retrospective, Real-World Data Study
por: Yoo, Jee Hee, et al.
Publicado: (2019)

Triglyceride Glucose-Waist Circumference Better Predicts Coronary Calcium Progression Compared with Other Indices of Insulin Resistance: A Longitudinal Observational Study
por: Cho, Yun Kyung, et al.
Publicado: (2020)

Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
por: Han, Man-Hoon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v8835503i3dnt284l3qh91ctru